BioSig Technologies, Inc. STEX Net Change in Cash
Net Change in Cash at other companies
Other financials
Where this comes from
Reported directly by BioSig Technologies, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.
The official record: BioSig Technologies, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about BioSig Technologies, Inc.'s net change in cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is BioSig Technologies, Inc.'s net change in cash?
- BioSig Technologies, Inc. (STEX) reported net change in cash of -$13.46M in Q1 2026.
- How has BioSig Technologies, Inc.'s net change in cash changed year-over-year?
- BioSig Technologies, Inc.'s net change in cash decreased by 475.4% year-over-year, from $3.59M to -$13.46M.
- What is the long-term trend for BioSig Technologies, Inc.'s net change in cash?
- Over 2 years (2022 to 2025), BioSig Technologies, Inc.'s net change in cash has grown at a 36.6% compound annual growth rate (CAGR), from -$11.3M to $21.08M.
- What does net change in cash mean?
- Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.